North America narcolepsy market is anticipated to reach US$ 2,024.8 Mn in 2027 from US$ 919.6 Mn in 2018. The Narcolepsy market is expected to rise with a CAGR of 9.3% from 2019-2027.
The narcolepsy market is estimated to grow due to the key driving factors such as rising sleeping disorders and growing pharmaceutical industry. However, the market is expected to face restraining factors such as no cure treatment for narcolepsy
Download Full PDF Sample Copy of Market Report @- https://www.businessmarketinsights.com/sample/TIPRE00008100
Narcolepsy is a disorder of chronic neurological disorder; the disorder impacts the brain’s ability to control sleep and wake-up cycle. A person can get affected by the disorder in childhood, young age, or in adulthood, which from 17 years to 25 years. The most widely seen symptoms seen are excessive daytime sleepiness, cataplexy, sleep paralysis, and hallucinations. The disorder is a frequent disorder among the people across the North American region and is the second leading cause of excessive daytime sleepiness. According to the National Organization for Rare Disorder, it is stated that the incidences of narcolepsy are 1 in 2,000. Similarly, as per the National Institute of Neurological Disorders and Stroke, it is estimated that across the United States, nearly 135,000 to 200,000 people are living narcolepsy.
The rise in sleep disorders is impacting the working efficiency of people, and it is also affecting the performance of children in the studies. Similarly, it is affecting older people. The disorder increases the risk as the age grows, and it may stop breathing activity during sleep time. According to the studies published by Oxford Academics in April 2018, it is stated that the incidences are widely seen among women. The study also stated that the incidences were higher among the people between 21–30 years of age group. It is also expected that narcolepsy is caused by environmental exposures before the age of beginning in genetically inclined individuals.
It is expected that the incidences of sleep disorders are likely to grow in the coming years. Sleep disorders have become a great concern among the people of the North American region. Over 50 million people in the region are suffering from more than 80 different sleep disorders, and nearly 20 to 30 million are living with recurrent sleep disorders every year. Thus, rising sleeping disorders are likely to demand treatment for narcolepsy, which will eventually lead to the growth of the market in the coming future.
North America Narcolepsy Strategic Insights
Strategic insights for the North America Narcolepsy provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
North America Narcolepsy Report Scope
| Attribute | Details |
| Market Size (2018) | US$ 919.6 Million |
| Market Size (2027) | US$ 2,024.8 Million |
| CAGR (2019–2027) | 9.3% |
| Historical Data | 2016–2017 |
| Forecast Period | 2019–2027 |
| Segments by Type | Narcolepsy with Cataplexy, Narcolepsy without Cataplexy, Secondary Narcolepsy |
| Segments by Product | CNS Stimulants, Sodium Oxybate, Antidepressants |
| Distribution Channels | Hospital Pharmacies, Retail Pharmacies |
| Regions Covered | North America (US, Canada, Mexico) |
| Key Companies | Teva, Jazz, Arena, Graymark, Novartis, Takeda, Mylan, BIOPROJET, Shionogi, Ligand |
North America Narcolepsy Regional Insights
The geographic scope of the North America Narcolepsy refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
North America Narcolepsy – Market Segmentation
| Category | Segments |
| By Type | – Narcolepsy with Cataplexy – Narcolepsy without Cataplexy – Secondary Narcolepsy |
| By Product | – CNS Stimulants – Sodium Oxybate – Antidepressants |
| By Distribution Channel | – Hospital Pharmacies – Retail Pharmacies |
| By Geography | – US – Canada – Mexico |
| Key Companies | – Teva Pharmaceutical Industries Ltd. – Jazz Pharmaceuticals plc – Arena Pharmaceuticals, Inc. – Graymark Healthcare, Inc. – Novartis AG – Takeda Pharmaceutical Company Limited – Mylan N.V. – BIOPROJET – Shionogi & Co., Ltd. – Ligand Pharmaceuticals, Inc |
Can you see this our reports –
Europe Heat Exchanger Market – https://medium.com/@ap2494002/europe-heat-exchanger-market-trends-size-segment-and-growth-by-forecast-to-2030-6f0323d988b9
Europe Machine Condition Monitoring Market – https://postyourarticle.com/europe-machine-condition-monitoring-market-trends-size-segment-and-growth-by-forecast-to-2030-2/
Europe Plant Extracts Market – https://businessmarketins02.blogspot.com/2025/04/europe-plant-extracts-market-trends_20.html
Europe Electronic Power Steering Market – https://www.openpr.com/news/3973815/europe-electronic-power-steering-market-trends-size-segment
North America Heavy Construction Equipment Market – https://sites.google.com/view/businessmarketinsight-6/home
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Défense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications
Author’s Bio
Akshay
Senior Market Research Expert at Business Market Insights
